EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Across the Social Network of the Gut: Bacterial, Fungal, and Viral Determinants of Checkpoint Inhibitor Efficacy and Toxicity

Andreea Laura Antohi iD, Andreea Daria Gheorghiță, Octavian Andronic iD, Gratiela Gradisteanu Pircalabioru iD, Andreea-Ramona Treteanu iD

International Journal of Molecular Sciences · 10.03.2026 · 27 (6) · 2538

DOI: 10.3390/ijms27062538 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.03.2026. Verfasst von Andreea Laura Antohi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Gastrointestinal Microbiome, Neoplasms, Fungi. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unitatea Executiva Pentru Finantarea Invatamantului Superior Si A Cercetarii Stiintifice Universitare, HORIZON-WIDERA-2022-TALENTS-01, Development of genomic research in Romania-ROGEN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent findings suggest that the gut microbiome significantly influences cancer outcomes, including responses to immune checkpoint inhibitor (ICI) treatments. Although early research focused on gut bacteria, it is now understood that the microbiome includes a bacteriome, virome, and mycobiome, all of which can modulate host immunity. Some commensal bacteria enhance anti-tumor immune responses and improve ICI efficacy, as demonstrated in both mice and patients. Fecal microbiota transplants (FMT) from patients responding to ICI have successfully reversed resistance in certain non-responders. In addition to bacteria, gut fungi and viruses are gaining attention as further factors influencing ICI effectiveness and toxicity. Recent multi-omics studies across cancer cohorts show that fungal and viral populations in the gut vary between ICI responders and non-responders. Commensal fungi may shape anti-cancer immunity by inducing inflammatory or tolerogenic pathways, while viral components can stimulate innate immune sensors that promote tumor surveillance. On the other hand, gut dysbiosis marked by expansion of pathobionts (including opportunistic fungi) and reduction in beneficial microbes is linked to serious immune-related adverse events (irAEs) such as ICI-induced colitis. This review discusses the multi-kingdom gut microbiome–bacteria, fungi, and viruses–and their interactions with the immune system in cancer therapy. We emphasize known mechanisms linking these microbes to anti-tumor immunity, overview human studies associating gut microbiome profiles with ICI outcomes and explore strategies to modulate the microbiome to enhance ICI efficacy while reducing toxicity. Understanding and utilizing the gut mycobiome and virome in conjunction with the bacteriome could pave the way for new biomarkers and therapeutic adjuvants in cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsGastrointestinal MicrobiomeNeoplasmsFungiHumansAnimalsBacteriaDysbiosisFecal Microbiota TransplantationViruses

Stichwörter der Autor:innen

cancerfecal microbiota transplantgut microbiomeimmune checkpoint inhibitormycobiomevirome

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.
  • Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 37 Dionisie Lupu Street, 020021 Bucharest, Romania.
  • Innovation and eHealth Center, Carol Davila University of Medicine and Pharmacy, 37 Dionisie Lupu Street, 020021 Bucharest, Romania.
  • Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, 030018 Bucharest, Romania.
  • Research Institute of University of Bucharest (ICUB), University of Bucharest, 050095 Bucharest, Romania.
  • eBio-Hub Centre of Excellence in Bioengineering, National University of Science and Technology Politehnica Bucharest, 060042 Bucharest, Romania.

ORCID-Profile: Andreea Laura Antohi, Octavian Andronic, Gratiela Gradisteanu Pircalabioru, Andreea-Ramona Treteanu

Förderung

  • Unitatea Executiva Pentru Finantarea Invatamantului Superior Si A Cercetarii Stiintifice Universitare
  • HORIZON-WIDERA-2022-TALENTS-01
  • Development of genomic research in Romania-ROGEN

Zitieren

APA

Antohi, A. L., Gheorghiță, A. D., Andronic, O., Gradisteanu Pircalabioru, G., & Treteanu, A. R. (2026). Across the Social Network of the Gut: Bacterial, Fungal, and Viral Determinants of Checkpoint Inhibitor Efficacy and Toxicity. International Journal of Molecular Sciences, 27(6), 2538. https://doi.org/10.3390/ijms27062538

Vancouver

Antohi AL, Gheorghiță AD, Andronic O, Gradisteanu Pircalabioru G, Treteanu AR. Across the Social Network of the Gut: Bacterial, Fungal, and Viral Determinants of Checkpoint Inhibitor Efficacy and Toxicity. International Journal of Molecular Sciences. 2026;27(6):2538. doi:10.3390/ijms27062538

BibTeX
@article{Antohi2026,
  author = {Antohi, Andreea Laura and Gheorghiță, Andreea Daria and Andronic, Octavian and Gradisteanu Pircalabioru, Gratiela and Treteanu, Andreea-Ramona},
  title = {Across the Social Network of the Gut: Bacterial, Fungal, and Viral Determinants of Checkpoint Inhibitor Efficacy and Toxicity},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2538},
  doi = {10.3390/ijms27062538}
}
Kostenlos starten →